Literature DB >> 8391125

Possible role of phospholipase C in the induction of Ca(2+)-paradox in rat heart.

S Persad1, A Vrbanova, J T Meij, V Panagia, N S Dhalla.   

Abstract

In order to investigate the involvement of phosphoinositide-specific phospholipase C (PLC), an enzyme associated with phosphoinositide signal transduction pathway, for the occurrence of Ca(2+)-paradox (loss of contractile activity associated with contracture), rat hearts perfused with Ca(2+)-free medium (1 to 5 min) were reperfused (5 to 10 min) with medium containing 1.25 mM Ca2+. Crude membranes isolated from hearts perfused with Ca(2+)-free medium exhibited a significantly increased activity of PLC, whereas normal activity was detected in hearts reperfused with Ca(2+)-containing medium. A significant rise in PLC activity was observed at 1 min of Ca(2+)-free perfusion; maximal increase was seen at 4 min of Ca(2+)-free perfusion. Minimal concentration of Ca2+ in the perfusion medium required for showing an increase in PLC activity was 10 microM, whereas that required for the occurrence of Ca(2+)-paradoxic changes in heart function upon reperfusion was 50 microM. Perfusion of the hearts with Ca(2+)-free medium in the presence of low Na+ or at low temperature, which prevents the occurrence of Ca(2+)-paradox upon reperfusion, did not prevent the increase in PLC activity. An increase during Ca(2+)-free perfusion similar to that seen for PLC was also observed for two other enzymes, namely the phosphatidylinositol (PI) 4-kinase and the PI-4-monophosphate (PIP) 5-kinase, which synthesize the PLC substrate, phosphatidylinositol 4,5-bisphosphate (PIP2). No alteration of the alpha-adrenoreceptors was observed after 5 min of Ca(2+)-free perfusion. On the other hand, the observed changes in PLC activity during Ca(2+)-free perfusion appear to be due to some redistribution of the enzyme in the myocardium. These results suggest a possible role of the phosphoinositide/PLC pathway in the induction of Ca(2+)-paradox via mechanisms which do not appear to be associated with changes in the characteristics of alpha-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391125     DOI: 10.1007/bf00925978

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Pathways for the movements of ions during calcium-free perfusion and the induction of the 'calcium paradox'.

Authors:  J Tunstall; P Busselen; G C Rodrigo; R A Chapman
Journal:  J Mol Cell Cardiol       Date:  1986-03       Impact factor: 5.000

2.  The calcium paradox: a reaffirmation.

Authors:  T J Ruigrok; F J Burgersdijk; A N Zimmerman
Journal:  Eur J Cardiol       Date:  1975-06

3.  Hydrolysis of myocardial lipids during acidosis and ischemia.

Authors:  W B Weglicki; K Owens; C W Urschel; J R Serur; E H Sonnenblick
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1973

4.  On the mechanism of the calcium paradox: the release of hydrolytic enzymes.

Authors:  W C Hülsmann
Journal:  Eur Heart J       Date:  1983-12       Impact factor: 29.983

5.  Sarcolemmal disruption during the calcium paradox.

Authors:  J A Post; P F Nievelstein; J Leunissen-Bijvelt; A J Verkleij; T J Ruigrok
Journal:  J Mol Cell Cardiol       Date:  1985-03       Impact factor: 5.000

6.  Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart.

Authors:  A N Zimmerman; W C Hülsmann
Journal:  Nature       Date:  1966-08-06       Impact factor: 49.962

7.  Enhanced phosphodiesteratic breakdown and turnover of phosphoinositides during reperfusion of ischemic rat heart.

Authors:  H Otani; M R Prasad; R M Engelman; H Otani; G A Cordis; D K Das
Journal:  Circ Res       Date:  1988-11       Impact factor: 17.367

8.  Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury.

Authors:  H Otani; R M Engelman; R H Breyer; J A Rousou; S Lemeshow; D K Das
Journal:  J Thorac Cardiovasc Surg       Date:  1986-08       Impact factor: 5.209

9.  Alterations in sarcolemmal adrenergic receptors due to intracellular Ca2+ overload in the myocardium.

Authors:  S Majumder; B Kropelin; N S Dhalla
Journal:  Cardioscience       Date:  1992-06

Review 10.  Calcium entry in the calcium paradox.

Authors:  P M Grinwald; W G Nayler
Journal:  J Mol Cell Cardiol       Date:  1981-10       Impact factor: 5.000

View more
  2 in total

1.  Various divalent cations protect the isolated perfused pigeon heart against a calcium paradox.

Authors:  C Gaitanaki; C Labrakakis; P Papazafiri; I Beis
Journal:  J Comp Physiol B       Date:  2004-04-16       Impact factor: 2.200

2.  Modification of heart sarcolemmal Na+/K+-ATPase activity during development of the calcium paradox.

Authors:  L E Alto; V Elimban; A Lukas; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.